Atlas Trials

Safety and Preliminary Efficacy of Anti-CDH17 CAR-T Cell Therapy in Patients with CDH17-positive Advanced Solid Tumors

Clinical trial NCT06820424 · RECRUITING

Trial details

NCT number
NCT06820424
Sponsor
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
Status
RECRUITING
Phase
Early Phase 1
Study type
INTERVENTIONAL
CDH17-positive Advanced Solid Tumors
Start date
2025-03-01
Primary completion
2028-01-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.